Identifying metabolic markers for preventing atrial fibrillation

Is this trial a fit for you?

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

This study aims to identify metabolic and biomolecular signatures associated with atrial fibrillation (AF) in patients scheduled for cardiac ablation. By monitoring these signatures over a 12-month period, the research seeks to develop a method for assessing the risk of AF recurrence. The approach combines traditional risk factors with metabolic biomarkers using machine learning techniques to enhance personalized prevention strategies. The ultimate goal is to improve outcomes for patients at risk of AF by providing tailored interventions.

Why it matters

Who can join: the full rules

Inclusion Criteria:

* Age ≥ 18 years, all genders, and ethnic origins
* Free, informed, and written consent signed
* Person affiliated to or benefiting from a social security scheme

Exclusion Criteria:

* Age \< 18 years
* Lack of informed consent
* Gestating women (pregnancy test carried out as part of care for FA patients, contraception, or menopause for women in control groups)
* Persons under administrative or judicial protection
* Endocarditis or pericarditis in progress or within the 3 last months
* Active tumor pathology (benign or malignant)
* Chronic inflammation or autoimmune disease
* Chronic liver disease
* Myocardial infarction within the last 8 weeks

Where it's running

• University Hospital of Bordeaux
  Pessac, France Recruiting

Study contacts

• Principal investigator: Nicolas DERVAL — University Hospital, Bordeaux
• Study coordinator: Guido CALUORI
• Email: guido.caluori@ihu-liryc.fr
• Phone: +33 5 35 38 19 58

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

• Pulsed Field vs Cryoballoon for Pulmonary Vein Isolation in Atrial Fibrillation

  This trial tests whether pulsed field ablation can shorten the procedure for first-time PVI in AF patients compared with cryoballoon ablation, while keeping safety and effectiveness similar.

  Recruiting St. Josefs-Hospital Wiesbaden GmbH · Wiesbaden · NCT07910370

• Pulsed Field Ablation vs Cryoablation for Atrial Fibrillation Under Deep Sedation

  This trial tests whether pulsed field ablation (PFA) done under deep sedation works as well as cryoballoon ablation for treating atrial fibrillation, aiming to avoid general anesthesia.

  Recruiting East Sussex Healthcare NHS Trust · Eastbourne · NCT07900685

• Bachmann’s Bundle Pacing vs Right Atrial Appendage Pacing for AF

  This study tests two common atrial pacing methods to see which one is safer over 12 months for people getting a new pacemaker, ICD, or CRT device.

  Recruiting Allegheny Singer Research Institute (also known as Allegheny Health Network Research Institute) · Pittsburgh, Pennsylvania · NCT07874763

• AI-powered ECG to help diagnose and predict outcomes in heart disease

  Researchers test an AI-enhanced ECG to help diagnose and predict outcomes for people with cardiovascular diseases.

  Recruiting Inha University Hospital · Incheon, Incheon · NCT07856472

• Pace-and-ablate strategy in atrial fibrillation: who benefits and long-term outcomes

  This study looks at adults with atrial fibrillation who underwent AV node ablation with permanent pacing to see who develops pacing-induced problems and how they do long-term.

  Recruiting at 5 sites Insel Gruppe AG, University Hospital Bern · Zabrze and 4 other locations · NCT07852221

• AI-based cardiac analysis using 12-lead and 1-lead ECG

  A clinician-facing pilot test to see if SmartECG-EF helps evaluate heart function using both 12-lead and single-lead ECGs in adults with heart conditions.

  Recruiting Inha University Hospital · Incheon, Incheon · NCT07844434

How to take part

1. Review the eligibility criteria above with your treating physician.
2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.